WO2000064460A3 - Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin - Google Patents
Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin Download PDFInfo
- Publication number
- WO2000064460A3 WO2000064460A3 PCT/IB2000/000480 IB0000480W WO0064460A3 WO 2000064460 A3 WO2000064460 A3 WO 2000064460A3 IB 0000480 W IB0000480 W IB 0000480W WO 0064460 A3 WO0064460 A3 WO 0064460A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- recovery
- mixture
- natural protein
- bone
- irreversible
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU36671/00A AU3667100A (en) | 1999-04-23 | 2000-04-19 | Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13074199P | 1999-04-23 | 1999-04-23 | |
US60/130,741 | 1999-04-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000064460A2 WO2000064460A2 (en) | 2000-11-02 |
WO2000064460A3 true WO2000064460A3 (en) | 2001-02-08 |
Family
ID=22446103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2000/000480 WO2000064460A2 (en) | 1999-04-23 | 2000-04-19 | Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3667100A (en) |
WO (1) | WO2000064460A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0400005A3 (en) | 2001-05-17 | 2012-09-28 | Serono Lab | Use of osteopontin for the treatment and/or prevention of neurologic diseases |
FI117667B (en) | 2001-07-05 | 2007-01-15 | Univ Zuerich | A pharmaceutical composition suitable for use in orthopedics and dentistry |
GB0207829D0 (en) * | 2002-04-04 | 2002-05-15 | Isis Innovations Ltd | Stimulation of nerve cell regeneration |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992015323A1 (en) * | 1991-03-11 | 1992-09-17 | Creative Biomolecules, Inc. | Protein-induced morphogenesis |
US5290763A (en) * | 1991-04-22 | 1994-03-01 | Intermedics Orthopedics/Denver, Inc. | Osteoinductive protein mixtures and purification processes |
WO1994005791A2 (en) * | 1992-09-03 | 1994-03-17 | Regeneron Pharmaceuticals, Inc. | Dorsal tissue affecting factor and compositions |
US5756457A (en) * | 1993-08-26 | 1998-05-26 | Genetics Institute, Inc. | Neural regeneration using human bone morphogenetic proteins |
WO1999015191A2 (en) * | 1997-09-19 | 1999-04-01 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Cytokines having neurotrophic activity |
-
2000
- 2000-04-19 WO PCT/IB2000/000480 patent/WO2000064460A2/en active Application Filing
- 2000-04-19 AU AU36671/00A patent/AU3667100A/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992015323A1 (en) * | 1991-03-11 | 1992-09-17 | Creative Biomolecules, Inc. | Protein-induced morphogenesis |
US5290763A (en) * | 1991-04-22 | 1994-03-01 | Intermedics Orthopedics/Denver, Inc. | Osteoinductive protein mixtures and purification processes |
WO1994005791A2 (en) * | 1992-09-03 | 1994-03-17 | Regeneron Pharmaceuticals, Inc. | Dorsal tissue affecting factor and compositions |
US5756457A (en) * | 1993-08-26 | 1998-05-26 | Genetics Institute, Inc. | Neural regeneration using human bone morphogenetic proteins |
WO1999015191A2 (en) * | 1997-09-19 | 1999-04-01 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Cytokines having neurotrophic activity |
Non-Patent Citations (3)
Title |
---|
FELDBLUM S ET AL: "New cocktail of bone morphogenic proteins promotes functional motor recovery in a model of traumatic spinal cord injury.", SOCIETY FOR NEUROSCIENCE ABSTRACTS., vol. 25, no. 1-2, 1999, 29th Annual Meeting of the Society for Neuroscience.;Miami Beach, Florida, USA; October 23-28, 1999, pages 1334, XP000953009, ISSN: 0190-5295 * |
LEVINE J P ET AL: "Bone morphogenetic protein promotes vascularization and osteoinduction in preformed hydroxyapatite in the rabbit", ANNALS OF PLASTIC SURGERY,US,LITTLE, BROWN AND CO, vol. 39, no. 2, August 1997 (1997-08-01), pages 158 - 168, XP002115397, ISSN: 0148-7043 * |
PERIDES G ET AL: "NEUROPROTECTIVE EFFECT OF HUMAN OSTEOGENIC PROTEIN-1 IN A RAT MODEL OF CEREBRAL HYPOXIA/ISCHEMIA", NEUROSCIENCE LETTERS,IE,LIMERICK, vol. 187, 1995, pages 21 - 24, XP002037656, ISSN: 0304-3940 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000064460A2 (en) | 2000-11-02 |
AU3667100A (en) | 2000-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wolfgram et al. | THE COMPOSITION OF THE MYELIN PROTEINS OF THE CENTRAL NERVOUS SYSTEM 1 2 | |
FI86362C (en) | FOERFARANDE FOER SEPARERING AV PROTEINER FRAON MJOELK OCH DESS DERIVE | |
Fillenz et al. | Selective uptake and retrograde axonal transport of dopamine-β-hydroxylase antibodies in peripheral adrenergic neurons | |
EP2514445A3 (en) | Bioactive hydrogel compositions | |
EP1420031A3 (en) | Bone morphogenetic protein (BMP)-18 compositions | |
JPH0873324A (en) | Hair-tonic and hair-growing agent | |
Tuross | Albumin preservation in the Taima-taima mastodon skeleton | |
WO2000064460A3 (en) | Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin | |
Fujii et al. | Isolation of skeletal muscle collagen | |
RU2011121684A (en) | PROTEIN-polypeptide complex (LTP) has a tissue specific regenerative-reparative and anti-aging effect on skin tissue, METHOD FOR PRODUCING PROTEIN-polypeptide complex having a tissue specific regenerative-reparative and anti-aging effect on skin tissue, and pharmaceutical compositions having tissue specific regenerative-reparative action on LEATHER TISSUE, FOR MEDICINES FOR THE TREATMENT OF AUTOIMMUNE, VASCULAR, TRAUMATIC, TOXIC SKIN DISEASES, Also in aesthetic medicine and cosmetology | |
WO1996032117A1 (en) | Bioactive concentrate, its producing method and certain drug compositions containing also chondroitin sulphate | |
RU2001116296A (en) | The method of obtaining soy protein product | |
Korneluk et al. | Stage dependency of forelimb regeneration on nerves in postmetamorphic froglets of Xenopus laevis | |
ES2367523T3 (en) | COSMETIC COMPOSITION CONTAINING CYNARA CARDUNCULUS OR SILYBUM MARIANUM OILS. | |
Brunish et al. | Composition of histone prepared from rat liver deoxypentosenucleoprotein | |
Rikkers et al. | Vitamin D binding globulin in the rat: Specificity for the vitamins D | |
US20120071414A1 (en) | Method for producing and using active principles of limestone | |
Tator et al. | Effect of triiodo-L-thyronine on axonal regeneration in the rat spinal cord after acute compression injury | |
Nagata et al. | Effect of degeneration of sympathetic ganglion cells on amino acid metabolism in cervical ganglion from the rat | |
Medgyesi | Investigation into the carrying ability of pedicled bone grafts during transplantation | |
WO2004071524A1 (en) | Albumin solution and method for the production thereof | |
CN101232893A (en) | Pharmaceutical composition for the treatment of nerve damage comprising blood plasma or serum | |
Krampitz et al. | Simultaneous binding of calcium and bicarbonate by conchiolin of oyster shells | |
Darlington et al. | Comparison of the effects of ACTH-(4–10) on medial vestibular nucleus neurons in brainstem slices from labyrinthine-intact and compensated guinea pigs | |
WO2011092350A1 (en) | Product for the preparation of dermatological, cosmetic or cosmeceutical compositions intended for skin treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |